Prevalence of extended spectrum β-lactamases among Enterobacteriaceae:: an Italian survey

被引:18
作者
Bonfiglio, G
Perilli, M
Stefani, S
Amicosante, G
Nicoletti, G
机构
[1] Univ Catania, Dipartimento Sci Microbiol, I-95124 Catania, Italy
[2] Univ Aquila, Dipartimento Sci & Tecnol Biomed, I-67100 Laquila, Italy
关键词
ESBL; beta-lactamase; Enterobacteriaceae; survey;
D O I
10.1016/S0924-8579(01)00497-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The prevalence of extended-spectrum beta-lactamase (ESBL) production by consecutive non-repeated isolates of Enterobacteriaceae was determined over a 6-month period. A total of 8015 strains were isolated from ten Italian laboratories and 509 (6.3%) of these were designated ESBL producers from the results of a double-disk synergy test. Eseherichia coli was the most isolated microrganism, followed by Klebsiella pneumoniae and Proteus mirabilis. Providencia stuartii (28.1%) was the most frequently isolated ESBL producer, followed by K. pneumoniae and Enterobacter aerogenes (20.5%). However, amongst all ESBL producers, K. pneumoniae (38.2%) was the most represented followed by P. mirabilis (25.7%). All the strains positive to DID tests were confirmed for the carriage of TEM and SHV genes using colony-blot hybridisation (CH). A total of 447 strains (88.0%) were CH-positive, of which 42.3% hybridised with the TEM-type probe, 30.1% with the SHV-type probe and 15.6% with both probes. In conclusion, our findings indicate that 6.3% of all Enterobacteriaceae tested produced ESBLs, 42.3% of which were TEM-derived enzymes. More than 20% of P. stuartli, K. pneumoniae and E. aerogenes harbour these enzymes. The double-disk test seems to be a useful test to identify ESBL producing strains. (C) 2002 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 27 条
[1]  
AMICOSANTE G, 2000, P 40 INT C ANT AG CH
[2]  
AMICOSANTE G, 1992, P 40 INT C ANT AG CH
[3]   Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998 [J].
Babini, GS ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (02) :183-189
[4]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[5]   A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France [J].
De Champs, C ;
Sirot, D ;
Chanal, C ;
Bonnet, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3177-3179
[6]   First isolation of a CTX-M-3-producing Enterobacter cloacae in France [J].
Doucet-Populaire, F ;
Ghnassia, JC ;
Bonnet, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3239-3240
[7]   Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center [J].
Emery, CL ;
Weymouth, LA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (08) :2061-2067
[8]   Ceftazidime and aztreonam resistance in Providencia stuartii:: Characterization of a natural TEM-derived extended-spectrum β-lactamase, TEM-60 [J].
Franceschini, N ;
Perilli, M ;
Segatore, B ;
Setacci, D ;
Amicosante, G ;
Mazzariol, A ;
Cornaglia, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1459-1462
[9]   CHARACTERIZATION OF CEFTRIAXONE-RESISTANT ENTEROBACTERIACEAE - A MULTICENTER STUDY IN 26 FRENCH HOSPITALS [J].
GOLDSTEIN, FW ;
PEAN, Y ;
ROSATO, A ;
GERTNER, J ;
GUTMANN, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (04) :595-603
[10]  
JARLIER V, 1988, REV INFECT DIS, V10, P867